Treace Medical Concepts, Inc. TMCI Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Treace Medical Concepts, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Treace Medical Concepts, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Treace Medical Concepts, Inc.'s return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Treace Medical Concepts, Inc.'s return on equity?
- Treace Medical Concepts, Inc. (TMCI) reported return on equity of -66.9% in Q1 2026.
- How has Treace Medical Concepts, Inc.'s return on equity changed year-over-year?
- Treace Medical Concepts, Inc.'s return on equity decreased by 46.2% year-over-year, from -45.7% to -66.9%.
- What is the long-term trend for Treace Medical Concepts, Inc.'s return on equity?
- Over 4 years (2021 to 2025), Treace Medical Concepts, Inc.'s return on equity has grown at a 7.7% compound annual growth rate (CAGR), from -43.8% to -58.9%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.